Abstract
Primary lymphoproliferative tumors of the mediastinum, similarly to their counterparts in the lymph nodes, have undergone significant changes over the last decade. These changes have been not only in terms of classification but also in terms of new approaches regarding their diagnosis. Needless to say, particularly in the mediastinum, the significant developments in our understanding of these tumors have modified older concepts and terms that may have created confusion in the literature. Terms such as granulomatous thymoma have been correctly reinterpreted as Hodgkin’s lymphoma and in turn have provided significant changes in the treatment and survival of these patients. In this chapter we will focus our discussion in those tumors occurring in the mediastinum. In addition, the chapter will be presented from the practical point of view for the practicing pathologist who may be called upon to interpret these lesions. In cases in which the utility of more advanced studies is needed, specific mention of it will be made. However, the chapter will focus more on the histopathological and immunohistochemical approach to mediastinal lymphoproliferative lesions. In addition, it is important to highlight that the focus will be on primary mediastinal lymphomas and not on the involvement of the mediastinum by lymphoma as a systemic disease. This chapter will discuss non-Hodgkin’s lymphoma (large B-cell lymphoma/primary mediastinal B-cell lymphoma, gray zone lymphoma, anaplastic large cell lymphoma, MALT lymphoma), lymphoblastic lymphoma, Hodgkin’s lymphoma, dendritic cell tumors, plasmacytoma, Castleman’s disease, and extramedullary hematopoiesis (as mediastinal tumor).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Remigio PA. Granulomatous thymoma associated with erythroid hyperplasia. Am J Clin Pathol. 1971;55:68–72.
Strickler JG, Kurtin PJ. Mediastinal lymphoma. Semin Diagn Pathol. 1991;8:2–13.
Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, et al. Non-Hodgkin’s lymphomas. Clinicopathologic correlation of 405 cases. Cancer. 1973;31:806–23.
Chabner BA, Johnson RE, Young RC, Canellos GP, Hubbard SP, Johnson SK, et al. Sequential non-surgical and surgical staging of non-Hodgkin’s lymphoma. Ann Intern Med. 1976;85:149–54.
Manoharan A, Pitney WR, Schonell ME, Bader LV. Intrathoracic manifestations in non-Hodgkin’s lymphoma. Thorax. 1979;34:29–32.
Goffinet DR, Warnke R, Dunnick NR, Castellino R, Glatstein E, Nelsen TS, et al. Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin’s lymphoma. Cancer Treat Rep. 1977;61:981–92.
Lukes RJ, Butler JJ, Hicks EB. Natural history of Hodgkin’s disease as related to its pathological picture. Cancer. 1966;19:317–44.
Colby TV, Hoppe RT, Warnke RA. Hodgkin’s disease: a clinicopathologic study of 659 cases. Cancer. 1981;49:1848–58.
Lichtenstein AK, Levine A, Taylor CR, Boswell W, Rossman S, Feinstein DI, et al. Primary mediastinal lymphoma in adults. Am J Med. 1980;68:509–14.
Benjamin SP, McCormack LJ, Effler DB, Groves LK. Primary lymphatic tumors of the mediastinum. Cancer. 1972;30:708–12.
Al-Naaman YD, Al-Ani M, Al-Omeri M. Primary mediastinal tumours. Thorax. 1974;29:475–81.
Adkins RB, Maples MD, Hainsworth JD. Primary malignant mediastinal tumors. Ann Thorac Surg. 1984;38:648–59.
Glick RD, La Quaglia MP. Lymphomas of the anterior mediastinum. Semin Pediatr Surg. 1999;8:69–77.
Suster S. Primary large cell lymphomas of the mediastinum. Semin Diagn Pathol. 1999;16:51–64.
Petersdorf SH, Wood DE. Lymphoproliferative disorders presenting as mediastinal neoplasms. Semin Thorac Cardiovasc Surg. 2000;12:290–300.
Barth TFE, Leithauser F, Joos S, Bentz M, Möller P. Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol. 2002;3:229–34.
Faris JE, LaCasce AS. Primary mediastinal large B-cell lymphoma. Clin Adv Hematol Oncol. 2009;7:125–33.
Martelli M, di Rocco A, Russo E, Perrone S, Foà R. Primary mediastinal lymphoma: diagnosis and treatment options. Exp Rev Hematol. 2015;8(2):173–86.
Bhatt VR, Mourya R, Shrestha R, Armitage JO. Primary mediastinal large B-cell lymphoma. Cancer Treat Rev. 2015;41:476–85.
Aggarval R, Rao S, Dhawan S, Bhalla S, Kumar A, Chopra P. Primary mediastinal lymphomas, their morphological features and comparative evaluation. Lung India. 2017;34:19–24.
Liu PP, Wang KF, Xia Y, Bi XW, Sun P, Wang Y, et al. Racial patterns of patients with primary mediastinal large B-cell lymphoma. Medicine. 2016;95:27(e4054).
Maeshima AM, Taniguchi H, Suzuki T, Yuda S, Toyoda K, Yamauchi N, et al. Distribution of malignant lymphomas in the anterior mediastinum: a single institution study of 76 cases in Japan 1997-2016. Int J Hematol. 2017;106:675–80.
Martelli M, Ferreri A, Di Rocco A, Ansuinelli M, Johnson PWM. Primary mediastinal B-cell lymphoma. Crit Rev Oncol Hematol. 2017;113:318–27.
Zinzani PL, Piccaluga PP. Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies. Curr Oncol Rep. 2011;13:407–15.
Trump DL, Mann RB. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. A poor prognostic subset of patients with non-Hodgkin’s lymphoma. Cancer. 1982;50:277–82.
Levitt LJ, Aisenberg AC, Harris NL, Linggood RM, Poppema S. Primary non-Hodgkin’s lymphoma of the mediastinum. Cancer. 1982;50:2486–92.
Yousem SA, Weiss LM, Warnke RA. Primary mediastinal non-Hodgkin’s lymphomas: a morphologic and immunologic study of 19 cases. Am J Clin Pathol. 1985;83:676–80.
Waldrom JA, Dohring EJ, Farber LR. Primary large cell lymphoma of the mediastinum: an analysis of 20 cases. Semin Diagn Pathol. 1985;2:282–95.
Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol. 1986;10:176–91.
Menestrina F, Chilosi M, Bonetti F, Lestani M, Scarpa A, Novelli P, et al. Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases. Histopathology. 1986;10:589–600.
Addis BJ, Isaacson PG. Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin. Histopathology. 1986;10:379–90.
Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp MA, Kaplan WD, et al. Large cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol. 1993;11:1336–43.
Abou-Elella AA, Weisenburger DD, Vose JM, Kollath JP, Lynch JC, Bast MA, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska lymphoma study group. J Clin Oncol. 1999;17:784–90.
Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d'Agay MF, Baumelou E, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphoma, a GELA (“Groupe d’Etude des Lymphomes de l’Adulte”). Am J Surg Pathol. 1996;20:877–88.
Paulli M, Strater J, Gianelli U, Rousset M-T, Gambacorta M, Orlandi E, et al. Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases. Hum Pathol. 1999;30:178–87.
Piira T, Perkins SL, Anderson AT, Meadows AT, Chilcote RR, Kadin M, et al. Primary mediastinal large cell lymphoma in children: a report from the childrens cancer group. Pediatr Pathol Lab Med. 1995;15:561–70.
Carr TF, Lockwood L, Stevens RF, Morris-Jones PH, Lewis I, DaCosta PE, et al. Childhood B cell lymphomas arising in the mediastinum. J Clin Pathol. 1993;46:513–6.
Dunleavy K. Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies. Hematology. 2017;2017:298–304.
Ahn HJ, Yoon DH, Kim S, Lee K, Kang E, Huh J, et al. Primary mediastinal large B-cell lymphoma: a single center experience in Korea. Blood Res. 2014;49:36–41.
Fiascone S, Datkhaeva I, Winer ES, Rizak T. Primary mediastinal large B-cell lymphoma in pregnancy. Leuk Lymphoma. 2016;57:240–3.
Pileri S, Zinzani PL, Gaidano G, Falini B, Gaulard P, Zucca E, et al. Pathobiology of primary mediastinal B-cell lymphoma. Leuk Lymphoma. 2003;44(supplement 3):S21–6.
Lazzarino M, Orlandi M, Paulli M, Sträter J, Klersy C, Gianelli U, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol. 1997;15:1646–53.
Zinzani PL, Martelli M, Magagnoli M, Pescarmona E, Scaramucci L, Palombi F, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regime and mediastinal radiotherapy monitored by 67Gallium scan in 50 patients. Blood. 1999;94:3289–93.
Todeschini G, Secchi S, Morra E, Vitolo U, Orlandi E, Pasini F, et al. Primary mediastinal large B-cell lymphoma (PMBCL): long term results from a retrospective multicenter Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer. 2004;90:372–6.
Broccoli A, Casadei B, Stefoni V, Pellegrini C, Quirini F, Tonialini L, et al. The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients. BMNC Cancer. 2017;17:276–83.
Giulino-Roth L, O'Donohue T, Chen Z, Bartlett NL, LaCasce A, Martin-Doyle W, et al. Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. Br J Haematol. 2017;179:739–47.
Pillon M, Carraro E, Mussolin L, Conter V, Tondo A, Aricò M, et al. Primary mediastinal large B-cell lymphoma: outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20. Pediatr Blood Cancer. 2018;65:e26855.
Moller P, Lammler B, Eberlein-Gonska M, Feichter GE, Hofmann WJ, Schmitteckert H, et al. Primary mediastinal clear cell lymphoma of B-cell type. Virchows Arch [Pathol Anat]. 1986;409:79–92.
Suster S, Moran CA. Pleomorphic large cell lymphoma of the mediastinum. Am J Surg Pathol. 1996;20:224–32.
Calaminici M, Piper K, Lee AM, Norton AJ. CD23 expression in mediastinal large B-cell lymphomas. Histopathology. 2004;45:619–24.
Higgins JP, Warnke RA. CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol. 1999;112:241–7.
Copie-Bergman C, Gaulard P, Maouche-Chretien L, Brière J, Haioun C, Alonso MA, et al. The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood. 1999;94:3567–75.
Tsang P, Cesarman E, Chadburn A, Liu YF, Knowles DM. Molecular characterization of primary mediastinal B-cell lymphoma. Am J Pathol. 1996;148:2017–25.
Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca E, et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB1, and PU.1 in the absence of immunoglobulins. Am J Pathol. 2003;162:243–53.
Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin’s lymphoma. Blood. 2003;102:3871–9.
Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851–62.
Joos S, Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood. 1996;87:1571–8.
Wang Z, Cook JR. PDCD1LG2 (PD-L2) RNA in situ hybridization is a sensitive specific, and practical marker of primary mediastinal large B-cell lymphoma. Br J Haematol. 2018;181(4):564–6.
Garcia JF, Mollejo M, Fraga M, Forteza J, Muniesa JA, Pérez-Guillermo M, et al. Large B-cell lymphoma with hodgkin’s features. Histopathology. 2005;47:101–10.
Gomez-Gelvez JC, Smith LB. Reed-Sternberg-like cells in non-Hodgkin’s lymphoma. Arch Pathol Lab Med. 2015;139:1205–10.
Traverse-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso MA, Raffeld M, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin’s lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29:1141–421.
Oschlies I, Burkhardt B, Salaverria I, Rosenwald A, d’Amore ES, Szczepanowski M, et al. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphomas in children. Haematologica. 2011;96:262–8.
Dunleavy K. Management of primary mediastinal B-cell lymphoma and gray zone lymphoma. Oncology. 2017;6:499–501.
Salama M, Mariappan MR, Inamdar K, Tripp SR, Perkins SL. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin’s lymphoma. Int J Surg Pathol. 2010;18:121–8.
Hoeller S, Zihler D, Zlobec I, Obermann EC, Pileri SA, Dirnhofer S, et al. BOB.1, CD79a, and cyclin E are the most appropriate markers to discriminate classical Hodgkin’s lymphoma from primary mediastinal large B-cell lymphoma. Histopathology. 2010;56:217–28.
Etienne B, Guillaud PH, Loire R, Coiffier B, Berger F, Cordier JF. Aggressive primary mediastinal non-Hodgkin’s lymphomas: a study of 29 cases. Eur Respir J. 1999;13:1133–8.
Gonin J, Kadiri H, Bensaci S, Le Tourneau A, Molina TJ, Diebold J, et al. Primary mediastinal anaplastic alk-2-positive large cell lymphoma of T/NK-cell type expressing CD20. Virchows Arch. 2007;450:355–8.
Isaacson PG, Chan JKC, Tang C, Addis BJ. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the thymus. A thymic lymphoma mimicking myoepithelial sialadenitis. Am J Surg. 1990;14:342–51.
Nagasaka T, Lai R, Harada T, Chen YY, Chen WG, Arber DA, et al. Coexisting thymic and gastric lymphomas of mucosa-associated lymphoid tissues in a patient with Sjogren’s syndrome. Arch Pathol Lab Med. 2000;124:770–3.
Moriyama E, Yokose T, Kodama T, Matsuno Y, Hojo F, Takahashi K, et al. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue in the thymus of a patient with pulmonary amyloid nodules. Jpn J Clin Oncol. 2000;30:349–53.
Kamimura K, Nakamura N, Ishibashi T, Maruyam Y, Abe M. Somatic hypermutation of immunoglobulin heavy chain variable region genes in thymic marginal zone B-cell lymphoma of MALT type of a patient with Sjogren’s syndrome. Histopathology. 2002;40:292–304.
Sunada K, Hasegawa Y, Kodama T, Anami Y, Satoh H, Ohtsuka M, et al. Thymic and pulmonary mucosa-associated lymphoid tissue lymphomas in a patient with Sjogren syndrome and literature review. Respirology. 2007;12:144–7.
Yamada S, Tadasu K, Mingyon M, Yoshiaki A, Noriko M. Mucosa-associated lymphoid tissue lymphoma of the thymus resected using combined thoracoscopic and transcervical approaches. Ann Thorac Surg. 2003;76:293–5.
Kim JM. Primary extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type in the thymus of a patient with Sjogren’s syndrome and rheumatoid arthritis. J Korean Med Sci. 2003;18:897–900.
Kuroki S, Nasu K, Murakami K, Hayashi T, Sekiguchi R, Nishida H, et al. Thymic MALT lymphoma MR imaging findings and their correlation with histopathological findings on four cases. J Clin Imaging. 2004;28:272–7.
Ortone N, Copie-Bergman C, Remy P, Delfau-Larue MH, Alonso MA, Mariette X, et al. Mucosa-associated lymphoid tissue lymphoma of the thymus: a case report with no evidence of MALT1 rearrangement. Virchows Arch. 2005;446:189–93.
Nakamura S, Koshikawa T, Kaba S, Tokoro Y, Suchi T, Kurita S. Imprint cytology of low-grade B-cell lymphoma of mucosa-associated lymphoid tisdsue arising in the thymus: a case report. Diagn Cytopathol. 1993;9:665–7.
Takagi N, Nakamura S, Yamamoto K, Kunishima K, Takagi I, Suyama M, et al. Malignant lymphoma of mucosa-associated lymphoid tissue arising in the thymus of a patient with Sjogren’s syndrome. Cancer. 1992;69:1347–55.
Parrens M, Dubus P, Danjoux M, Jougon J, Brousset P, Velly JF, et al. Mucosa-associated lymphoid tissue of the thymus. Hyperplasia vs lymphoma. Am J Clin Pathol. 2002;117:51–6.
Inagaki H, Chan JKC, Ng JWM, Okabe M, Yoshino T, Okamoto M, et al. Primary thymic extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol. 2002;160:1435–43.
Shimizu K, Ishii G, Nagai K, Yokose T, Ishizawa K, Tamaru J, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in the thymus: report of four cases. Jpn J Clin Oncol. 2005;35:412–6.
Sunohara M, Hara K, Osamura K, Tashiro N, Shibuya H, Nakahara K, et al. Mucosa associated lymphoid tissue (MALT) lymphoma of the thymus with trisomy 18. Intern Med. 2009;48:2025–32.
Kitai R, Sasaki M, Sato K, Kubota T, Takeuchi H, Imamura Y. Thymic mucosa-associated lymphoid tissue lymphoma associated with bilateral orbital pseudotumor. Gen Thorac Cardiovasc Surg. 2009;57:566–9.
Sakamoto T, Yamashita K, Mizumoto C. MALT lymphoma of the thymus with Sjogren’s syndrome: biphasic changes in serological abnormalities over a 4-year period following thymectomy. Int J Hematol. 2009;89:709–13.
Maeda A, Hayama M, Nakata M, Masaki H, Tanemoto K. Mucosa associated lymphoid tissue lymphoma in the thymus of a patient with systemic lupus erythematosus. Gen Thorac Cardiovasc Surg. 2008;56:288–91.
Kinoshita N, Ashizawa K, Abe K, Yamasaki N, Nakamura A, Tagawa T, et al. Mucosa-associated lymphoid tissue lymphoma of the thymus associated with Sjogren’s syndrome: report of a case. Surg Today. 2008;38:436–9.
Harigae H, Ichinohasama R, Miura I, Kameoka J, Meguro K, Miyamura K, et al. Primary marginal zone lymphoma of the thymus accompanied by chromosomal anomaly 46,X,dup(X)(p11p22). Cancer Genet Cytogenet. 2002;133:142–7.
Yamasaki S, Matsushita H, Tanimura S, Nakatani T, Hara S, Endo Y, et al. B-cell lymphoma of mucosa-associated lymphoid tissue of the thymus: a report of two cases with a background of Sjogren’s syndrome and monoclonal gammopathy. Hum Pathol. 1998;29:1021–4.
McCluggage WG, McManus K, Qureshi R, McAleer S, Wotherspoon AC. Low-grade B-cell lymphoma of mucosa associated lymphoid tissue (MALT) of thymus. Hum Pathol. 2000;31:255–9.
Lorsbach RB, Pinkus GS, Shahsafaei A, Dorfman DM. Primary marginal zone lymphoma of the thymus. Am J Clin Pathol. 2000;113:784–91.
Weissferdt A, Moran CA. Primary MALT-type lymphoma of the thymus: a clinicopathological and immunohistochemical study of six cases. Lung. 2011;189:461–6.
Sternberg C. Leukosarcomatose and myeloblastenleukaamie. Beitr Pathol. 1916;61:75.
Cooke JV. Mediastinal tumor in acute leukemia. A clinical and roentgenologic study. Am J Dis Child. 1932;44:1153.
Smith JL, Clein GP, Barker CR, Collins RD. Characterisation of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin. Lancet. 1973;1:74.
Barcos MGP, Lukes RJ. Malignant lymphoma of the convoluted lymphocytes. A new entity of possible T-cell type. In: Sinks L, Godden J, editors. Conflicts in childhood Cancer: an evaluation of current management. New York: Liss; 1975. p. 147.
Nathwani BN, Kim H, Rappaport H. Malignant lymphoma, lymphoblastic: a clinicopathologic study of 95 patients. Cancer. 1976;48:2347.
Borowitz MJ, Falletta JM. Leukemias and lymphomas of thymic differentiation. Clin Lab Med. 1988;8:119–34.
Cortelazzo S, Ponzoni M, Ferreri AJM, Hoelzer D. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2011;79:330–43.
Han X, Kilfoy B, Zheng T, Holford TR, Zhu C, Zhu Y, et al. Lymphoma survival patterns by WHO subtype in the United States, 1973-2003. Cancer Causes Control. 2008;19:841–58.
Swerdlow SH, Campo E, Harris N, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC; 2008.
Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Eur J Haematol. 2015;96:447–60.
Portell CA, Sweetenham JW. Adult lymphoblastic lymphoma. Cancer J. 2012;18:432–8.
Le Gouill S, Lepretre S, Briere J, Morel P, Bouabdallah R, Raffoux E, et al. Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials. Leukemioa. 2003;17:2220–4.
Cortelazzo S, Ferreri A, Hoelzer D, Ponzoni M. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2017;113:304–17.
Mlika M, Khanfir D, Mansouri R, El-Mezni F. Multivariate analysis of prognostic factors of lymphoblastic lymphomas of the mediastinum. Ann Hematol. 2016;95:1731–2.
Thomas DA, Kantarjian HM. Lymphoblastic lymphoma. Hematol Oncol Clin North Am. 2001;15:51–95.
Schwartz EE, Conroy JF, Bonner H. Mediastinal involvement in adults with lymphoblastic lymphoma. Acta Radiol. 1987;28:403–7.
Macon WR, Rynalski TH, Swedlow SH, Cousar JB. T-cell lymphoblastic leukemia/lymphoma presenting in a recurrent thymoma. Mod Pathol. 1991;4:524–8.
Liu KL, Herbrecht R, Tranchant C, Gasser B, Warter JM, Wihlm JM, et al. Malignant thymic lymphoblastic lymphoma and myasthenia gravis: an exceptional association. Nouv Rev Fr Hematol. 1992;34:221–3.
Posner MR, Said J, Pinkus GS, Nadler LM, Hardy R, Flatow F, et al. T-cell lymphoblastic lymphoma with subsequent acute nonlymphocytic leukemia. Cancer. 1982;50:118–24.
Hvizdala EV, Berard C, Callihan T, Falletta J, Sabio H, Shuster JJ, et al. Lymphoblastic lymphoma in children –a randomized trial comparing LSA2 L2 with the A-COP+ therapeutic regime: a pediatric oncology group study. J Clin Oncol. 1988;6:26–33.
Patte C, Kalifa C, Flamant F, Hartmann O, Brugières L, Valteau-Couanet D, et al. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol. 1992;20:105–13.
Sander CA, Jaffe ES, Gebhardt FC, Yano T, Medeiros LJ. Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. Am J Surg Pathol. 1992;16:300–5.
Manning JT, Pugh WC, El-Naggar A, Ordonez NG. Mediastinal lymphoblastic lymphoma with non-lymphoblastic histologic features. Mod Pathol. 1994;7:59–63.
Sweetenham JW. Lymphoblastic lymphoma in adults. Curr Hematol Malig Rep. 2006;1:241–7.
Dawson PJ. The original illustrations of Hodgkin’s disease. Ann Diagn Pathol. 1999;3:386–93.
Aisenberg AC. Historical review. Br J Haematol. 2000; 109:466–76.
Dawson PJ. Whatever happened to Dorothy reed? Ann Diagn Pathol. 2003;7:195–203.
Reed DM. On the pathological changes in Hodgkin’s disease, with especial reference to its relation to tuberculosis. Johns Hopkins Rep. 1902;10:113–96.
Jackson H, Parker F. Hodgkin’s disease.VI. Clinical diagnosis. NEJM. 1946;234:37–41.
Tsang RW, Hodgson DC, Crump M. Hodgkin’s lymphoma. Curr Probl Cancer 2006;30:107–58.
Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang J-S, et al. Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. NEJM. 2003;349:1324–32.
Piña-Oviedo S, Moran CA. Primary mediastinal classical Hodgkin’s lymphoma. Adv Anat Pathol. 2016;23(5):285–309.
Katz A, Lattes R. Granulomatous thymoma or Hodgkin’s disease of the thymus. Cancer. 1969;23:1–15.
Fechner RE. Hodgkin’s disease of the thymus. Cancer. 1969;1:16–23.
Keller AR, Castleman B. Hodgkin’s disease of the thymus gland. Cancer. 1974;33:1615–23.
Smetana HF, Cohen BM. Mortality in relation to histologic type of Hodgkin’s disease. Blood. 1956;11:211–24.
Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin’s disease. Cancer Res. 1966;26:1063–81.
MacLennan KA, Bennett MH, Tu A, Hudson BV, Easterling MJ, Hudson GV, et al. Relatioship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin’s disease. A study of 1659 patients. Cancer. 1989;64:1686–93.
Ferry JA, Linggood RM, Convery KM, Efird JT, Eliseo R, Harris NL. Hodgkin’s disease, nodular sclerosis type. Implications of histologic subclassification. Cancer. 1993;71:457–63.
Hess JL, Bodis S, Pinkus G, Silver B, Mauch P. Histopathologic grading of nodular sclerosis Hodgkin’s disease. Lack of prognosticd significance in 254 surgically staged patients. Cancer. 1994;74:708–14.
Heron CW, Husband JE, Williams MP. Hodgkin disease: CT of the thymus. Radiology. 1988;167:647–51.
Priola AM, Priola SM. Primary mediastinal Hodgkin lymphoma and rebound thymic hyperplasia: differentiation with chemical-shift magnetic resonance imaging after treatment. Int J Haematol. 2009;90:8–10.
Schmid C, Pan L, Diss T, Isaacson PG. Expression of B-cell antigens by Hodgkin’s and reed-Sternberg cells. Am J Pathol. 1991;139:701–7.
Harris JA, Jain S, Ren Q, Zarineh A, Liu C, Ibrahim S. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin’s lymphoma. Diagn Pathol. 2012;7:12–7.
Kupper R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, et al. Hodgkin disease: Hodgkin and reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B-cells at various stages of development. Proc Natl Acad Sci. 1994;91:10962–6.
Kanzler H, Kuppers R, Hansmann ML, Rajewsky K. Hodgkin and reed-Sternberg cells in Hodgkin’s disease represents the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184:1495–505.
Kuppers R, Hansmann ML. The Hodgkin and Reed/Sternberg cell. Int J Biochem Cell Biol. 2005;37:511–7.
Kuppers R. The biology of Hodgkin’s lymphoma. Nat Rev Cancer. 2009;9:15–27. https://doi.org/10.1038/nrc2542.
Monda L, Warnke R, Rosai J. A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. A report of 4 cases. Am J Pathol. 1986;122:562–72.
Le BE, Korst RJ, Taskin M. Right pneumonectomy for resection of a posterior mediastinal follicular dendritic cell sarcoma arising from Castleman’s disease. Ann Thorac Surg. 2014;97:e101–3.
Hu J, Dong D, Jiang Z, Hu H. Clinicopathological characgteristics of mediastinal follicular dendritic cell sarcoma: report of three cases. J Cardiothorac Surg. 2016;11:56–9.
Viola P, Vroobel KM, Devaraj A, Jordan S, Ladas G, Dusmet M, et al. Follicualr dendritic cell tumour/sarcoma: a commonly misdiagnosed tumour in the thorax. Histopathology. 2016;69:752–61.
Hartert M, Strobel P, Dahm M, Nix W, Marx A, Vahl CF. A follicular dendritic cell sarcoma of the mediastinum with immature T-cells and association with myasthenia gravis. Am J Surg Pathol. 2010;34:742–5.
Jiang L, Admirand JH, Moran CA, Ford RJ, Bueso-Ramos CE. Mediastinal follicular dendritic cell sarcoma with involving bone marrow: a case report and review of the literature. Ann Diagn Pathol. 2006;10:357–62.
Gupta RM, Roy DC, Gupta IM, Khanna S. Extramedullary plasmacytoma IgG type I presenting as mediastinal syndrome. Br J Dis Chest. 1974;68:65.
Arbona GL, Loyd TV, Lucas J. Mediastinal extramedullary plasmacytoma. South Med J. 1981;73:670.
Moran CA, Suster S, Fishback NF, Koss MN. Extramedullary plasmacytoma presenting as mediastinal masses: clinicoparthologic study of two cases preceding the onset of multiple myeloma. Mod Pathol. 1995;8:257–9.
Ahmed R, Marchbank AJ, Nicholson AG, Wotherspoon AC, Ladas GP. Extramedullary plasmacytoma presenting with myasthenia gravis and mediastinal mass. Ann Thorac Surg. 2000;70:1390–2.
Lee SY, Kim JH, Shin JS, Shin C, In KH, Kang KH, et al. A case of extramedullary plasmacytoma arising from the posterior mediastinum. Korean J Intern Med. 2005;20:173–6.
Wetherbe ER, Dincer HE. IgG myeloma presenting as a large mediastinal mass and pleural effusion. J Bronchology Interv Pulmonol. 2012;19:65–7.
Sato K, Fumimoto S, Fukada T, Chihashi Y, Ochi K, Satomi H, et al. Extramedullary plasmacytoma arising from the anterior mediastinum. Ann Thorac Surg. 2017;103:e393–5.
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 1956;9:822–30.
Inada K, Kawai K, Katsumura T, Nakano A. Giant lymph node hyperplasia if mediastinum: case report with review of literature. Am Rev Resp Dis. 1959;79:232–7.
Katz I, Dziadiw R. Localized mediastinal lymph node hyperplasia: report of case with roentgen findings simulating porterior mediastinal neurofibroma. Am J Roentgenol Radium Ther Nucl Med. 1960;84:206–12.
Wolfel DA, Antonius JI, Cowley A. Posterior mediastinal lymph node hyperplasia. Am J Roentgenol. 1964;91:120–4.
Lattes R, Pachter M. Benign lymphoid masses of probable hamatomatous nature: analysis of 12 cases. Cancer. 1962;15:197–214.
Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670–83.
Karcher DS, Pearson CE, Butler WM, Hurwitz MA, Cassell PF. Giant lymph node hyperplasia involving the thymus with associated nephrotic syndrome and myelofibrosis. Am J Clin Pathol. 1982;77:100–4.
Regal MAH, Aljehani YM, Bousbalt H. Primary mediastinal Castleman’s disease. Rare Tumors. 2010;2:e11.
Shah S, Shah S. Posterior mediastinal Castleman’s disease: a case report. Indian J Surg Oncol. 2010;1:343–5.
Ishikawa K, Kato T, Aragaki M, Ohbuchi T, Kimura S, Matsui Y, et al. A case of Castleman’s disease with myasthenia gravis. Ann Thorac Cardiovasc Surg. 2014;20(supplement):585–8.
Kim CH, Jeong JS, Kim SR, Choe YH, Park HS, Lee YC. Coexistence of mediastinal Caatleman’s disease with spindle cell carcinoma of the lung. Am J Respir Crit Care Med. 2017;196:652–4.
Yu JY, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC, et al. Castleman’s disease presenting as a tracheal mass. Ann Thorac Surg. 2014;97:1798–800.
Hussein H, Khawar M, Cherry M, Youness H. Castleman’s disease presenting as a mediastinal mass: mimicker of malignancy. Am J Med. 2016;129:e67–8.
Paci M, Valli R, Renconi S, Sgarbi G. Mediastinal Castleman’s disease mimicking thoracic paravertebral schwannoma. Interact Cardiovasc Thorac Surg. 2011;13:346–7.
Aoki M, Otsuka T, Yanagi M, Yokomakura N, Nagata T, Nakamura Y, et al. A case of resected plasma cell type of Castleman’s disease with intramediastinal lymph node spread. Ann Thorac Cardiovasc Surg. 2014;20(supplement):682–5.
Nistor C, Davidescu M, Giuche A, Bluoss C, Motaş N, Motaş C, et al. A rare case of unicentric plasma cell type Castleman’s disease in the mediastinum. Pneumologia. 2010;59:32–5.
Haro A, Kuramitsu E, Fukuyama Y. Complete resection of unicentric Castleman disease in the superior mediastinum: a case report. Int J Surg Case Rep. 2016;25:44–7.
Slater B, Nordin AB, Allen CE, Elghetany MT, Heinle JS, Kim ES. Resection of mediastinal Castleman’s disease: a case report. Pediatr Hematol Oncol. 2013;30:554–6.
Lorenz JM, Zangan SM, Leef JA. Mediastinal Castleman’s disease: embolization without surgery. J Vasc Interv Radiol. 2009;20:1393–4.
Hountis P, Dedeilias P, Douzinas M. The management of Castleman’s disease of the mediastinum: a case report. Cases J. 2008;1:330.
Fajgenbaum DC, Shilling D. Castleman disease pathogenesis. Hematol Oncol N Am. 2018;32:11–21.
Parravinci C, Coprbellino M, Pauli M, Magrini U, Lazzarino M, Moore PS, et al. Expression of a virus-derived cytokine, KSHV vL-6, in HIV seronegative Castleman’s disease. Am J Pathol. 1997;151:1517–22.
Wu D, Lim MS, Jaffe ES. Pathology of Castleman disease. Hematol Oncol Clin N Am. 2018;32:37–52.
Simpson D. Epidemiology of Castleman disease. Hematol Oncol Clin N Am. 2018;32:1–10.
Van Rhee F, Greenway A, Stone K. Treatment of idiopathic Castleman disease. Hematol Oncol Clin N Am. 2018;32:89–106.
Szalat R, Munshi NC. Diagnosis of Castleman disease. Hematol Oncol Clin N Am. 2018;32:53–64.
Knoblich R. Extramedullary hematopoiesis presenting as intrathoracic tumors. Report of a case in a patient with thalassemia minor. Cancer. 1960;13:462–8.
Da Costa JL, Loh YS, Hanam E. Extramedullary hemopoiesis with multiple tumor-simulating mediastinal masses in hemoglobin E-thalasemia disease. Chest. 1974;65:210–2.
Cantinella FP, Boyd AD, Spencer FC. Intrathoracic extramedullary hematopoiesis simulating anterior mediastinal tumor. J Thorac Cardiovasc Surg. 1985;89:580–4.
Verani R, Olson J, Moake JL. Intrathoracic extramedullary hematopoiesis. Report of a case in a patient with sickle-cell disease –beta-thalasemia. Am J Clin Pathol. 1980;73:133–7.
Krag D, Reich S. Heteropic marrow (myelolipoma) of the mediastinum. Chest. 1972;61:514.
Covey GW. Erythroblastosis: report of a cases presenting erythroblastic tumor in thoracic cavity. Am J Pathol. 1935;11:551.
Hanford RB, Schneider GP, McCarthy JD. Massive thoracic extramedullary hematopoiesis. N Engl J Med. 1960;263:120.
Andras C, Lassen KP, Holaday WJ. Tumor simulating intrathoracic extramedullary hematopoiesis. Ann Thorac Surg. 1970;10:75.
Condon WB, Safarik LR, Elzi EP. Extramedullary hematopoiesis simulating intra-thoracic tumor. Arch Surg. 1965;90:643.
Foster JBT. Primary thoracic myelolipoma: case report. AMA Arch Pathol. 1958;65:295.
Varizi M, Sadeghipour A, Pazooki A, Shoolami LZ. Primary mediastinal myelolipoma. Ann Thorac Surg. 2008;85:1805–6.
Loh CK, Alcorta C, McElhinney J. Extramedullary hematopoiesis simulating posterior mediastinal tumors. Ann Thorac Surg. 1996;61:1003–5.
Moran CA, Suster S, Fishback N, Koss MN. Extramedullary hematopoiesis presenting as posterior mediastinal mass: a study of four cases. Mod Pathol. 1995;8:249–51.
Albert S, Wolf PL, Pryjma I, Vasquez J. Erythropoiesis in the human thymus. Am J Clin Pathol. 1966;45:460–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kalhor, N., Moran, C. (2019). Lymphoproliferative Disorders. In: Mediastinal Pathology . Springer, Cham. https://doi.org/10.1007/978-3-319-98980-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-98980-8_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98979-2
Online ISBN: 978-3-319-98980-8
eBook Packages: MedicineMedicine (R0)